Raymond James Financial Services Advisors, Inc. Axonics, Inc. Transaction History

Raymond James Financial Services Advisors, Inc.

$73.5 Billion
Q3 2024

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$39.5 - $64.42 $3,713 - $6,055	-94 Reduced 1.81%	5,113 $290,000
Q1 2022 May 11, 2022	BUY	$43.74 - $62.76 $14,259 - $20,459	326 Added 6.68%	5,207 $326,000
Q4 2021 Feb 08, 2022	SELL	$50.01 - $73.35 $48,659 - $71,369	-973 Reduced 16.62%	4,881 $273,000
Q3 2021 Nov 02, 2021	SELL	$59.21 - $78.66 $15,572 - $20,687	-263 Reduced 4.3%	5,854 $381,000
Q2 2021 Aug 11, 2021	BUY	$51.39 - $66.9 $5,550 - $7,225	108 Added 1.8%	6,117 $388,000
Q1 2021 May 14, 2021	BUY	$49.14 - $59.89 $295,282 - $359,879	6,009 New	6,009 $360,000

Others Institutions Holding AXNX

# of Institutions

234

Shares Held

42.1M

Call Options Held

83.4K

Put Options Held

65.3K

Vanguard Group Inc Valley Forge, PA

5.06M
Shares

$359 Million
0.01% of portfolio
Black Rock Inc. New York, NY

4.34M
Shares

$308 Million
0.01% of portfolio
Alpine Associates Management Inc. Englewood Cliffs, NJ

2.18M
Shares

$155 Million
6.99% of portfolio
Fil LTD Hamilton, D0

2.04M
Shares

$145 Million
0.14% of portfolio
Westchester Capital Management, LLC Valhalla, NY

1.45M
Shares

$103 Million
4.89% of portfolio

View Full List

About Axonics, Inc.

Ticker AXNX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 49,123,600
Market Cap $3.49B
Description
Axonics, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence and non-obstructive urinary retention...

More about AXNX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James Financial Services Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Raymond James Financial Services Advisors, Inc. with notifications on news.

Account